12:00 AM
 | 
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Phenylephrine hydrochloride injection regulatory update

FDA's Cardiovascular and Renal Drugs Advisory Committee voted 8-2 against recommending approval of an NDA from Hikma's West-Ward Pharmaceutical Corp. subsidiary for phenylephrine HCL injection to treat acute hypotension, including hypotension associated with shock...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >